Atto BioScience Raises $3M in Series A Financing | GenomeWeb

NEW YORK, Oct. 29 – Atto BioScience, a Rockville, Md.-based biotech company,  has raised $3 million in its first round of private equity financing, the company said on Monday.

Emerging Technology Partners led the financing round.

The capital will help Atto to finish the development and commercialization of its first high-throughput single-cell-imaging system. This system, scheduled to launch later this year, was developed in collaboration with a major US pharmaceutical company, Atto said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.